La Rosa Holdings Corp.
For the period ended Dec 31, 2025. Filed Jun 4, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Jun 4, 2026
LRHC$0.76-15.4%Stored close · as of Oct 16, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Consolidated Statement of Cash Flows
| Year Ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash Flows from Operating Activities: | ||
| Net loss | $(30,410,422) | $(14,349,996) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Stock-based compensation | 4,980,139 | 4,730,355 |
| Loss on issuance of senior secured convertible note and warrants | 128,836,250 | — |
| Change on fair value of convertible note and warrants | (31,163,415) | — |
| Gain on settlement of incremental warrants | (82,299,000) | — |
| Amortization and depreciation | 687,719 | 1,018,934 |
| Amortization of right-of-use assets | 588,914 | 561,654 |
| Change in fair value of derivatives | (899,874) | 1,338,506 |
| Amortization of debt discount and financing fees | 63,160 | 649,138 |
| (Gain) loss on extinguishment of debt | (3,961,075) | 777,558 |
| Impairment of goodwill and intangibles | 6,911,770 | 787,438 |
| Non-cash interest expense | 218,049 | 8,793 |
| Allowance for credit losses | 13,139 | 82,324 |
| Changes in Operating Assets and Liabilities: | ||
| Accounts receivable | (333,929) | (174,175) |
| Other assets | (24,849) | 15,387 |
| Accounts payable | 867,476 | 1,131,817 |
| Accrued expenses | (872,247) | 459,952 |
| Contract liabilities | 163,353 | 7,747 |
| Security deposits and escrow payable | (320,204) | 524,854 |
| Operating lease liabilities | (573,813) | (567,593) |
| Net Cash Used in Operating Activities | (7,528,859) | (2,997,307) |
| Cash Flows from Investing Activities: | ||
| Purchase of property plant and equipment | — | (5,033) |
| Cash acquired through acquisition of businesses | — | (63,592) |
| Net Cash Provided by Investing Activities | — | (68,625) |
| Cash Flows from Financing Activities: | ||
| Borrowings on bank line of credit | 6,898 | 300,508 |
| Payments on bank line of credit | (155,874) | (151,532) |
| Proceeds from notes payable | 3,408,585 | 3,363,228 |
| Payments of deferred debt issuance costs | (138,895) | (459,094) |
| Payments on notes payable | (420,778) | (1,027,522) |
| Proceeds from advances on future receipts | — | 1,899,250 |
| Payments on advances on future receipts | (694,871) | (1,121,368) |
| Payments on post-acquisition consideration | (384,354) | (150,000) |
| Distributions to noncontrolling interest | — | (1,377,484) |
| Repurchase of derivative instruments issued | (379,083) | — |
| Proceeds from issuance of common stock | 7,610,896 | 2,928,685 |
| Withholding tax paid on behalf of employees on stock-based awards | — | (1,958) |
| Net Cash Provided by Financing Activities | 8,852,524 | 4,202,713 |
| Net Increase in Cash, Cash equivalents and Restricted Cash | 1,323,665 | 1,136,781 |
| Cash, Cash equivalents and Restricted Cash at Beginning of Period | 3,580,608 | 2,443,827 |
| Cash, Cash equivalents and Restricted Cash at End of Period | $4,904,273 | $3,580,608 |
| Supplemental Disclosures of Cash Flow Information: | ||
| Cash Paid During the Period for: | ||
| Interest | $291,566 | $335,425 |
| Non-Cash Activities | ||
| Issuance of Series B in exchange of incremental warrants | $8,261,000 | $— |
| Issuance of new convertible note | $8,364,000 | $— |
| Issuance of 282 shares of common stock as part of the settlement of notes payable and warrants | $812,153 | $— |
| Issuance of 4,629 shares of common stock for services rendered | $4,980,139 | $— |
| Issuance of 8,965 shares of common stock for conversion of liabilities | $2,222,563 | $— |
| Right of use assets obtained in exchange for lease obligations | $555,190 | $883,652 |
| Reclassification of non-contingent portion of Series X redemption price | $2,000,000 | $— |
| Derivative liability embedded in debt instruments | $— | $269,038 |
| Issuance of 356 shares of common stock as consideration of acquisitions of businesses | $— | $3,601,272 |
| Issuance of 49 shares of common stock as consideration of acquisitions of remaining non-controlling interest | $— | $377,485 |
| Issuance of 145 shares of common stock as part of the issuance of notes payable | $— | $1,076,768 |
| Issuance of 189 shares of common stock for services rendered | $— | $4,730,355 |
| Issuance of 30 shares of common stock for accounts payable | $— | $150,000 |
| Reconciliation of Cash, Cash equivalents and Restricted Cash | ||
| Cash and Cash equivalents | $3,086,770 | $1,442,901 |
| Restricted Cash | 1,817,503 | 2,137,707 |
| Cash, Cash equivalents and Restricted Cash | $4,904,273 | $3,580,608 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.